DrugCard vs Browse AI

Teams use DrugCard to automate local and global medical literature screening without reading every journal cover to cover. The service monitors 2200+ local journals across 146+ countries, handles 100+ languages, and bundles modules like Simple Search, Regulatory Intelligence, an adverse event database, and eCTDlight. Marketing Authorization Holders, CROs, and PV freelancers are the audiences highlighted on the homepage.

Where generic literature databases stop at keyword alerts, DrugCard focuses on local-language journals and scanned print copies. The vendor claims proprietary OCR reaches up to 99% accuracy on average-quality scans and that customers see 50-70% time savings versus manual screening, with the homepage citing 60% savings and up to 3 minutes per article instead of 35.

Teams buy through demo requests rather than self-serve checkout. DrugCard also sells LQPPV, signal management, PSUR, ICSR, PSMF, and risk management services for orgs that want outsourced pharmacovigilance help alongside the software.

Browse AI is a no-code web scraping and website monitoring platform that turns any site into structured, always-current data. You train robots with point-and-click actions to extract lists, details, and screenshots, then schedule runs or set change alerts without writing scripts.

The platform covers the full pipeline: scrape pages and subpages with deep scraping workflows, monitor sites for visual or content changes, and push results to Google Sheets, Airtable, Zapier, Make, webhooks, or a REST API. Over 250 prebuilt robots cover common sites like Amazon, Google Maps, and job boards so you can start from templates instead of building from scratch.

Browse AI targets analysts, operators, and growth teams who need competitor pricing, product catalogs, lead lists, or research feeds at scale. Premium managed services are available for complex or high-volume extraction with custom data delivery and onboarding.